文献速递心律失常

冷冻球囊与射频消融治疗持续性房颤:CRRF-PeAF试验

Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial.
PubMed 文献 · Eur Heart J · 2025-01-01

CRRF-PeAF是一项前瞻性、多中心、随机、非劣效性试验,纳入500例持续性房颤患者,比较冷冻球囊与射频消融的疗效与安全性。

要点

  • 冷冻球囊消融在持续性房颤1年房性快速性心律失常方面非劣效于射频消融。
  • 射频消融在1年左房逆向重构(左房容积指数下降)方面优于冷冻球囊。

核心结论

  • 在持续性房颤患者中,冷冻球囊消融在1年房性快速性心律失常发生率方面非劣效于射频消融。
  • 射频消融组1年左房容积指数下降幅度大于冷冻球囊组。

研究设计与样本

  • 前瞻性、多中心、随机、非劣效性临床试验,纳入500例持续性房颤患者,来自12个中心。
  • 最终分析499例,冷冻球囊组249例,射频组250例;中位年龄69岁(IQR 61-74)。
  • 主要终点为消融后90天空白期后1年内发生房性快速性心律失常。

主要发现

  • 意向性治疗分析中,主要终点在冷冻球囊组发生56例(22.5%),射频组58例(23.2%)。

临床怎么用

  • 对于持续性房颤,冷冻球囊消融可作为射频消融的非劣效替代选择。
  • 若关注左房逆向重构,射频消融可能更具优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: There are limited prospective data on the efficacy, safety, and impact on reverse remodelling of cryoballoon ablation as compared to radiofrequency ablation for persistent atrial fibrillation. METHODS: A prospective, multicentre, randomized, non-inferiority clinical trial was conducted to compare the efficacy and safety of cryoballoon vs radiofrequency ablation for persistent atrial fibrillation. A total of 500 patients with persistent atrial fibrillation were randomized across 12 centres. The primary endpoint was the occurrence of atrial tachyarrhythmias at 1 year with a 90-day blanking period after ablation. RESULTS: The final analysis included 499 patients, with a median age of 69 years (interquartile range, 61-74); 249 patients were allocated to the cryoballoon group, and 250 to the radiofrequency group. In the intention-to-treat analysis, the primary endpoint was observed in 56 patients (22.5%) in the cryoballoon group and 58 (23.2%) in the radiofrequency group, and the cryoballoon group demonstrated non-inferiority compared to the radiofrequency group for the primary endpoint (hazard ratio .99; 95% confidence interval, .69-1.43; P = .96). The radiofrequency group showed a greater reduction in left atrial size (left atrial volume index) at 1 year than the cryoballoon group [-11 mL/m2 (interquartile range, -19 to -4) vs -4 mL/m2 (interquartile range, -13 to 3), P < .001]. CONCLUSIONS: In this randomized trial, cryoballoon ablation was non-inferior to radiofrequency ablation for the occurrence of atrial tachyarrhythmias at 1 year in patients with persistent atrial fibrillation.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Miyamoto K, Kanaoka K, Yodogawa K, et al. Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial. Eur Heart J. 2025. PMID: 40704730. doi:10.1093/eurheartj/ehaf451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。